StemLab™ -
The Only Complete Laboratory Manufacturing Software Solution for Cellular Therapy

StemLab™ is designed to help manage data created by:

StemLab™ software supports the collection, processing, storage and distribution or administration of high-quality cellular therapy products. StemLab™ is specifically developed for academic laboratories, cord blood banks and biotech companies who manufacture cell therapy, gene therapy, and immune therapy products. StemLab™ is built to ensure quality and regulatory compliance standards are met by establishing procedural protocols, monitoring manufacturing processes, and documenting lot to lot traceability.

A proven bioinfomatics solution for cellular therapy

Our team of experienced technical and healthcare professionals have an average of 10 years experience focused exclusively on bioinformatics applications for cellular therapy. StemSoft has developed a unique central database model that integrates both clinical and laboratory cellular therapy data to support comprehensive outcome analyses.

Industry Knowledge

Having implemented our software solutions in over 65 cell processing and cord blood bank laboratories around the world, we understand the challenges, opportunities, and practicalities of the cellular therapy industry. In addition, StemSoft Software has long standing relationships with complementary clinical organizations working to establish central registries.

What Users are Saying:

"We have been using StemLab for since 2002, and it has proven to be amazingly flexible in meeting the challenges of not only transplant products, but also dendritic cells, autologous tumor cells, and most recently TIL. The program allows us to maintain our entire production records in a well structured, highly searchable, and secure database system. Support from STEMSOFT, particularly in the form of new versions of the software designed to keep pace with the evolving Cell Therapies regulatory universe, has been quite good. We have had inspectors for both FACT and AABB examine our use of StemLab, and they have left our facility duly impressed."
William E. Janssen, Ph.D. Director, Cell Therapies Core Facility
Moffitt Cancer Center, Tampa, Florida, U.S.A.

“An integral component of both our public cord blood banking program and our contract processing activities is the StemLab software from StemSoft. It has the flexibility to provide custom reporting for our clients, interfacing with our LIS to capture test results and manage our diverse inventories. Without the StemLab software, our program wouldn’t have grown to the extent it has”.
Dr. Dennis M. Todd, PhD President & CEO
Community Blood Services, Paramus, NJ, U.S.A